method
express
complet
sar
coronaviru
envelop
spike
protein
recombin
attenu
parainfluenza
viru
develop
live
attenu
intranas
paediatr
vaccin
human
parainfluenza
viru
type
immunis
eight
african
green
monkey
four
singl
dose
sarss
four
control
administ
via
respiratori
tract
sarscoronaviru
challeng
given
monkey
day
immunis
find
immunis
anim
induc
product
sarscoronavirusneutralis
serum
antibodi
indic
system
immun
respons
result
mucos
immunis
challeng
sar
coronaviru
monkey
control
group
shed
sar
coronaviru
shed
last
day
viral
shed
occur
group
immunis
sever
acut
respiratori
syndrom
sar
emerg
southeast
asia
late
subsequ
spread
intern
date
result
case
death
caus
agent
quickli
identifi
previous
unknown
member
coronavirida
famili
sar
infect
human
be
sinc
contain
infectioncontrol
measur
howev
resurg
still
threat
caus
agent
remain
anim
reservoir
fulli
understood
sporad
case
continu
report
incomplet
understand
genesi
sar
coronaviru
sarscov
may
potenti
emerg
variant
capabl
greater
transmiss
coronavirus
envelop
virus
genom
singl
strand
posit
sens
rna
kilobas
length
sequenc
analysi
rna
genom
sar
coronaviru
identifi
open
read
frame
encod
protein
typic
coronavirus
includ
envelop
spike
protein
viru
particl
sar
ill
human
chiefli
pneumonia
notwithstand
occurr
system
diseas
sign
detect
viru
viral
rna
organ
primari
mode
transmiss
sar
seem
mucos
membran
eye
nose
mouth
faecalor
transmiss
also
suggest
occurr
rel
import
yet
document
promin
role
respiratori
tract
sar
transmiss
diseas
suggest
direct
immunis
respiratori
mucosa
would
effect
strategi
immunoprophylaxi
sar
furthermor
mucos
immunis
respiratori
tract
live
attenu
respiratori
viru
vaccin
effici
induc
system
well
local
immun
approach
develop
vaccin
sar
coronaviru
took
advantag
exist
live
attenu
vaccin
viru
develop
intranas
paediatr
immunis
infect
diseas
deriv
bovin
b
closelyrel
bovin
counterpart
attenu
primat
natur
host
rangerestrict
also
shown
attenu
immunogen
human
candid
vaccin
modifi
previous
recombin
dna
method
replac
f
hn
protect
surfac
antigen
gene
counterpart
yield
improv
vaccin
sinc
bear
protect
antigen
exactli
match
studi
modifi
insert
transcript
cassett
contain
code
sequenc
fulllength
protein
sar
coronaviru
protein
chosen
studi
coronavirus
show
major
viral
surfac
protein
import
initi
infect
viru
growth
virolog
serolog
assay
propag
monkey
kidney
cell
viral
titr
determin
limit
dilut
cell
use
haemadsorpt
guinea
pig
erythrocyt
properti
hn
protein
detect
viru
infect
titr
express
unit
tissu
cultur
infecti
dose
tcid
similar
magnitud
plaqu
form
unit
serum
antibodi
specif
quantifi
haemagglutin
inhibit
hai
assay
dilut
serum
test
abil
block
agglutin
guinea
pig
erythrocyt
vitro
parallel
known
posit
neg
control
standard
sar
coronaviru
propag
vero
monkey
kidney
cell
viral
titr
measur
limit
dilut
cell
score
end
point
visibl
cytopatholog
serum
antibodi
specif
sar
coronaviru
quantifi
vero
cell
test
dilut
abil
neutralis
tcid
unit
sar
coronaviru
per
well
parallel
known
posit
neg
control
standard
sampl
involv
four
well
per
dilut
well
plate
viral
cytopath
effect
read
day
day
express
endpoint
detect
protein
cell
infect
control
viru
multipl
tcid
unit
infect
per
cell
cell
harvest
h
postinfect
addit
medium
overli
infect
cell
harvest
h
postinfect
viru
concentr
centrifug
g
h
viral
pellet
resuspend
subject
centrifug
wv
discontinu
sucros
gradient
g
min
band
viru
harvest
western
blot
analysi
done
nupag
protein
electrophoresi
system
westernbreez
immunodetect
kit
invitrogen
carlsbad
ca
usa
detect
protein
serum
sampl
mice
infect
sar
coronaviru
second
antibodi
alkalinephosphataseconjug
goat
antimous
igg
invitrogen
use
eight
young
adult
african
green
monkey
either
sex
bodyweight
kg
confirm
absenc
detect
serum
antibodi
sar
coronaviru
immunis
four
anim
four
use
singl
combin
intranas
intratrach
inocul
tcid
unit
viru
ml
inoculum
per
site
combin
dose
tcid
unit
anim
first
anaesthetis
ketamin
hydrochlorid
given
intramuscularli
dose
mgkg
place
dorsal
recumb
nostril
administ
addit
immunis
experiment
anim
protein
coronavirus
induc
virusspecif
immun
case
confer
protect
subsequ
challeng
investig
replic
immunogen
protect
effect
experiment
vaccin
african
green
monkey
cercopithecu
aethiop
urbani
strain
sar
coronaviru
provid
l
j
anderson
g
ksiazek
center
diseas
control
prevent
atlanta
ga
usa
propag
vero
cell
experi
involv
infecti
sar
coronaviru
done
approv
biosafeti
level
condit
viral
genom
rna
isol
use
rtpcr
synthesis
amplifi
bp
cdna
contain
complet
sarscoronaviru
code
sequenc
cdna
design
sar
code
sequenc
flank
short
transcript
signal
necessari
foreign
gene
express
transcript
program
vector
sequenc
oligonucleotid
primer
detail
rtpcr
dna
construct
avail
bukreyev
pcr
product
expect
length
purifi
insert
noti
restrict
endonucleas
site
previous
introduc
complet
clone
cdna
sequenc
insert
flank
region
confirm
configur
sarscoronaviru
insert
present
ad
gene
locat
p
gene
figur
would
express
separ
mrna
polymeras
certain
idiosyncrat
featur
molecular
genet
also
accommod
insert
design
genom
length
remain
even
multipl
six
requir
effici
replic
thought
reflect
nucleocapsid
space
requir
addit
insert
design
maintain
space
transcript
unit
within
hexam
organis
recombin
viru
recov
propag
cell
cultur
describ
elsewher
construct
recov
control
viru
use
method
describ
except
open
read
frame
insert
replac
foreign
sequenc
ident
length
deriv
complementari
copi
genom
human
ml
inoculum
steril
luer
syring
introduc
mm
nostril
intratrach
inocul
steril
stainless
steel
laryngoscop
use
observ
epiglotti
ml
inoculum
deliv
steril
flexibl
cathet
insert
cm
past
epiglott
open
use
separ
sterilis
instrument
everi
anim
nasopharyng
swab
taken
day
tracheal
lavag
done
day
titrat
done
describ
previous
tracheal
lavag
use
laryngoscop
cathet
place
describ
ml
wash
volum
phosphatebuff
salin
instil
aspir
back
sarscoronaviru
challeng
anim
given
similar
combin
intranas
intratrach
inocul
tcid
unit
viru
ml
inoculum
site
nasopharyng
swab
tracheal
lavag
obtain
schedul
use
initi
immunis
experi
done
approv
anim
biosafeti
level
facil
viru
titrat
done
describ
earlier
took
serum
sampl
day
immunis
day
day
challeng
day
day
post
challeng
day
analys
virusspecif
antibodi
describ
primat
studi
approv
nation
institut
health
usa
anim
care
use
committe
done
laboratori
approv
associ
assess
accredit
laboratori
anim
care
intern
sponsor
studi
role
studi
design
data
collect
data
analysi
data
interpret
write
report
ffemal
mmale
serum
sampl
taken
day
immunis
detect
hai
antibodi
detect
limit
reciproc
log
dilut
unit
detect
sarscoronavirusneutralis
antibodi
lower
limit
detect
reciproc
log
lower
limit
detect
viru
limit
detect
serum
neutralis
antibodi
topic
immunis
respiratori
tract
also
induc
detect
sarscoronavirusneutralis
serum
antibodi
evid
system
immun
respons
howev
postimmunis
titr
induc
almost
eightfold
lower
achiev
sarscoronaviru
infect
anim
differ
immunogen
might
reflect
natur
restrict
respiratori
tract
wherea
sar
coronaviru
dissemin
system
least
nonhuman
primat
evid
immunemedi
enhanc
infect
diseas
occur
one
coronaviru
felin
infecti
periton
viru
thu
result
show
one
mucos
immunis
vector
sar
protein
suffici
protect
shed
larg
challeng
dose
sar
coronaviru
cynomolgu
monkey
macaca
fasciculari
infect
sar
coronaviru
report
develop
clinic
diseas
sign
includ
transient
rash
respiratori
distress
lethargi
investig
three
speci
monkey
name
cynomolgu
rhesu
mulatta
african
green
monkey
permiss
sarscoronaviru
replic
possibl
diseas
unpublish
data
three
african
green
monkey
support
highest
level
replic
measur
viru
shed
henc
use
studi
none
anim
three
speci
develop
overt
diseas
sign
note
diseas
sign
studi
mice
ferret
cat
shown
support
high
level
pulmonari
sarscoronaviru
replic
infect
ferret
becam
letharg
assess
mice
vaccin
vector
sever
restrict
replic
anim
cat
ferret
model
recent
report
thu
although
studi
show
complet
protect
shed
challeng
viru
could
assess
whether
protect
would
afford
predict
full
length
unmodifi
protein
kda
potenti
glycosyl
site
evid
proteolyt
cleavag
sar
protein
two
subunit
occur
coronavirus
sinc
sarscoronaviru
protein
transmembran
virion
compon
also
envelop
viru
want
determin
whether
protein
incorpor
particl
western
blot
analysi
detect
protein
purifi
concentr
viru
particl
figur
lane
condit
direct
coomassi
stain
figur
lane
show
viral
protein
present
quantiti
greater
requir
detect
western
blot
absenc
signific
incorpor
protein
virion
suggest
express
would
unlik
affect
tropism
vector
safeti
factor
tabl
show
monkey
respons
immunis
analysi
nasal
swab
sampl
taken
immunis
show
peak
titr
vs
log
tcid
ml
durat
shed
vs
day
upper
respiratori
tract
differ
significantli
ctrl
analysi
tracheal
lavag
sampl
measur
shed
lower
respiratori
tract
show
two
four
anim
infect
detect
viru
shed
wherea
two
show
shed
day
less
anim
tabl
thu
express
sar
protein
attenu
effect
replic
vector
particularli
lower
respiratori
tract
nevertheless
induc
moder
titr
antibodi
measur
hai
assay
tabl
addit
induc
detect
level
serum
antibodi
neutralis
sarss
coronaviru
vitro
mean
reciproc
titr
log
tabl
show
respons
challeng
sar
coronaviru
four
monkey
immunis
shed
challeng
sar
coronaviru
upper
lower
respiratori
tract
contrast
none
anim
immunis
shed
sar
coronaviru
day
either
upper
lower
respiratori
tract
sarscoronavirusneutralis
serum
antibodi
titr
day
challeng
shown
tabl
increas
titr
group
challeng
could
result
immun
respons
antigen
present
viru
inoculum
low
level
replic
sar
coronaviru
nasal
swab
tracheal
lavag
sarscoronaviru
neutralis
titr
durat
day
peak
titr
durat
day
peak
titr
reciproc
log
log
tcid
ml
log
tcid
ml
ffemal
mmale
lower
limit
detect
viru
clinic
diseas
sign
studi
limit
unusu
respect
human
virus
experiment
anim
rare
provid
faith
model
infect
diseas
observ
human
diseas
sign
often
minim
alter
absent
measur
infecti
challeng
viru
secret
sampl
experiment
anim
gener
standard
measur
efficaci
viral
vaccin
assess
experiment
vaccin
nonhuman
primat
especi
import
view
phylogenet
anatom
similar
human
appropri
last
step
clinic
trial
attenu
version
activ
develop
vaccin
intranas
immunis
infant
young
children
vector
vaccin
also
express
protect
antigen
respiratori
pathogen
measl
viru
respiratori
syncyti
viru
metapneumoviru
effici
infect
respiratori
tract
spread
far
beyond
import
safeti
factor
vector
proven
effect
induc
local
system
immun
number
foreign
antigen
furthermor
safe
intranas
administr
attenu
relat
virus
shown
possibl
addit
safeti
featur
rna
recombin
almost
nonexist
natur
famili
virus
repres
wherea
recombin
extrem
frequent
coronavirus
potenti
recombin
circul
human
coronaviru
would
concern
liveattenu
sarscoronaviru
vaccin
viru
current
construct
vector
excel
candid
clinic
test
vaccin
like
highli
attenu
safe
effect
sar
infant
young
children
vector
would
replic
effici
vaccin
would
especi
use
transmiss
version
sar
coronaviru
emerg
immunis
infant
children
need
howev
replic
viral
vector
bear
protect
antigen
common
human
pathogen
adenoviru
unlik
replic
suffici
well
adult
immunogen
preval
neutralis
antibodi
pathogen
fortun
parainfluenza
virus
amen
swap
surfac
protein
without
loss
infect
vitro
vivo
therefor
possibl
replac
hn
f
surfac
protein
antigenicallydistinct
parainfluenza
viru
gener
popul
lack
immunityin
particular
one
mani
avian
parainfluenza
virus
attenu
strain
newcastl
diseas
viru
result
vector
would
use
sar
vaccin
mucos
immunis
entir
human
popul
resid
modern
psychiatr
ward
depress
grandmoth
opportun
daili
psychotherapi
attempt
compris
question
tell
feel
mind
rememb
sixth
session
back
away
chair
tri
get
away
even
though
chair
stuck
corner
place
go
liter
began
push
wall
stop
retrospect
children
suicid
clear
marker
inherit
affect
ill
rub
salt
old
wound
electroconvuls
treatment
work
perfectli
lesson
learnt
bewar
preconceiv
notion
ill
treatment
shift
paradigm
need
internship
gener
pediatr
ward
pretti
young
teenag
admit
excis
famili
pleasant
unsophist
modest
mean
grate
neurofibromatosi
requir
small
excis
year
unfortun
procedur
reveal
sarcoma
thigh
librari
small
chanc
surviv
assum
hip
disarticul
accord
case
seri
time
attend
physician
propos
amput
mother
patient
balk
seem
known
neurofibromatosi
might
take
want
opinion
almost
suggest
travel
bahama
brompton
cocktail
stifl
promis
discuss
later
went
trust
consult
oncologist
side
other
tri
best
chanc
close
rank
endors
treatmentonli
sudden
privat
viscer
sens
wrong
accept
amput
die
within
year
well
never
ask
want
die
lesson
learnt
bewar
assumpt
patient
life
prefer
ask
said
learn
entir
life
mistak
make
first
year
make
first
year
mistak
entir
life
case
illustr
long
cours
therapeut
humil
error
relat
invit
request
short
articl
full
issu
